Last reviewed · How we verify

NCT04719026: PEDICAD

PERIODONTAL HEALTH IN PATIENTS ACUTELY ADMITTED FOR MYOCARDIAL INFARCTION: A CASE CONTROL STUDY

Status unknown Last updated 22 January 2021
What this trial tests

trial testing Full-mouth periodontal examination using computerised Florida probe in Myocardial Infarction, Acute in 320 participants. Status unknown.

Timeline
16 February 2018
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorUniversity of Aberdeen
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment320
Start date16 February 2018
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Aberdeen

Who can join

Adults 20 to 90, any sex, with Myocardial Infarction, Acute or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heart attack remains a major cause of death in adult population worldwide and especially within Scotland. A large portion of the general population has an increased risk of suffering from a heart attack because of their genetic make-up, disease profile and lifestyle choices. Literature suggests that apart from these known risk factors, long-standing inflammation (reaction of tissues to infection or injury) elsewhere in the body may be responsible for heart attacks. It has been suggested that gum disease may be one such condition. If left untreated, gum disease may expose the entire body to a long-term inflammatory burden where inflammatory molecules can disseminate from the gums into the bloodstream and affect various body structures. This study explores the influence of gum disease on the risk of heart attack by comparing the gum health of participants who recently had a heart attack to the gum health of participants with no history of heart problems after accounting for other risk factors. Findings will provide critical information for the design of our forthcoming study to establish the effect of treatment of gum disease on the risk of heart attack, and its cost-effectiveness. Ultimately this research will tackle another risk factor for heart attacks and thus inform enhancement of public health prevention strategies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Myocardial infarction risk is increased by periodontal pathobionts: a cross-sectional study.
    Joshi C, Mezincescu A, Gunasekara M, Rudd A, et al · · 2022 · cited 4× · PMID 36329042 · DOI 10.1038/s41598-022-19154-z

Verify or expand the search:

Other recruiting trials for Myocardial Infarction, Acute

Currently open trials in the same condition.

Other University of Aberdeen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719026.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing